Pharmacokinetic characteristics of the triple inactivated plasma-derived Kedrion FIX concentrate: data from the KB037 clinical trial

by Massimo Morfini, Chiara Guarnieri, Roberta Macchia, Manuela Scarpellini, Prasad Mathew
Published 2020-10-01

Sucrose-Formulated Recombinant Factor VIII Dosing Flexibility in Prophylaxis Regimens: Experience from Postmarketing Surveillance Studies

by Thomas J. Humphries, Stephan Rauchensteiner, Claudia Tückmantel, Alexander Pieper, Monika Maas Enriquez, Prasad Mathew
Published 2015-01-01

Kikuchi-Fujimoto disease: Clinical and laboratory characteristics and outcome

by P S Rakesh, Reginald G Alex, George M Varghese, Prasad Mathew, Thambu David, Marie Therese Manipadam, Sheila Nair, Ooriapadickal Cherian Abraham
Published 2014-01-01

Detection of MYCN Gene Amplification in Neuroblastoma by Fluorescence In Situ Hybridization: A Pediatric Oncology Group Study

by Prasad Mathew, Marcus B. Valentine, Laura C. Bowman, Susan T. Rowe, Michael B. Nash, Virginia A. Valentine, Susan L. Cohn, Robert P. Castleberry, Garrett M. Brodeur, A. Thomas Look
Published 2001-01-01

Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study

by Runhui Wu, Xiaojing Li, Wanru Yao, Qing Zhang, Min Zhou, Ningning Zhang, Sheng Yang, Zhenping Chen, Yan Wang, Yangying Kuang, Ling Tang, Yingzi Zhen, Audrey Abad, Andrea S. Doria, Pamela Hilliard, Danial M. Ignas, Prasad Mathew, Derek Stephens, Victor S. Blanchette, Koon‐Hung Luke
Published 2021-08-01